New study shows promise of prebiotic fiber in managing Pre-Diabetes

A recent study published in the British Journal of Nutrition reveals promising results regarding the use of daily prebiotic fiber supplements in patients
with pre-diabetes, suggesting significant improvements in insulin sensitivity and other vital health markers.

“Pre-diabetes affects over 7 million individuals in the UK,” says Dr. Thomas Gurry, CEO at myota. “Our findings have shown that prebiotic fiber represents a
promising and efficacious fast-acting treatment to manage pre-diabetes.”

Conducted over 24 weeks with 66 prediabetic participants, the study, led by scientists from myota and CRO Lindus Health, utilised a diverse prebiotic blend.

“The results of our study suggest that this natural diverse prebiotic fiber supplement could be taken to reverse pre-diabetes and to prevent or slow the onset
of type 2 diabetes,” says Dr. Caitlin Hall, Head of Research at myota.